Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions

NCT07230301 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer Metastatic

Interventions

DRUG: Adebrelimab (PD-L1 inhibitor)

Sponsor

Sizhen Wang